Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12247858 | 0.80 | CA2 (0.46) | CA1CA2CA7CA13EPHX1 | |
| SCHEMBL19148366 | 0.79 | CA1 (0.46) | CA1CA2 | |
| SCHEMBL28435208 | 0.76 | CA1 (0.48) | CA1CA2CA7CA13EPHX1 | |
| SCHEMBL29691004 | 0.76 | CA2 (0.42) | CA1CA2CA7CA13EPHX1 | |
| SCHEMBL12247859 | 0.76 | CA1 (0.42) | CA1CA2CA7CA13EPHX1 | |
| SCHEMBL1725852 | 0.76 | CA2 (0.42) | CA1CA2CA7CA13EPHX1 | |
| SCHEMBL12247862 | 0.76 | CA1 (0.42) | CA1CA2CA7CA13EPHX1 | |
| SCHEMBL27207895 | 0.71 | — | — | |
| SCHEMBL10531548 | 0.70 | CA2 (0.37) | CA1CA2CA7CA13PTPN1 | |
| SCHEMBL21918063 | 0.70 | CA1 (0.37) | CA1CA2EPHX1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024043340-A1 | LITHIUM ION SECONDARY BATTERY | セントラル硝子株式会社 | 2024-02-29 | — | — | WO | disclosed |
| EP-3993120-A1 | NONAQUEOUS ELECTROLYTE AND NONAQEUOUS ELECTROLYTE SECONDARY BATTERY | Central Glass Co., Ltd. (JP) | 2022-05-04 | — | — | EP | disclosed |
| US-11230564-B2 | Method for producing phosphoryl imide salt, method for producing nonaqueous electrolyte solution containing said salt, and method for producing nonaqueous secondary battery | CENTRAL GLASS CO., LTD. (JP) | 2022-01-25 | — | — | US | disclosed |
| US-11171361-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | CENTRAL GLASS CO., LTD. (JP) | 2021-11-09 | — | — | US | disclosed |
| US-11145904-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | CENTRAL GLASS CO., LTD. (JP) | 2021-10-12 | — | — | US | disclosed |
| US-20210313624-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | CENTRAL GLASS CO., LTD. (JP) | 2021-10-07 | — | — | US | disclosed |
| US-10991983-B2 | Nonaqueous electrolytic solution and nonaqueous electrolytic solution secondary battery | CENTRAL GLASS COMPANY LIMITED (JP) | 2021-04-27 | — | — | US | disclosed |
| US-20210054005-A1 | METHOD FOR PRODUCING PHOSPHORYL IMIDE SALT, METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SAID SALT, AND METHOD FOR PRODUCING NONAQUEOUS SECONDARY BATTERY | CENTRAL GLASS CO., LTD. (JP) | 2021-02-25 | — | — | US | disclosed |
| US-20210028493-A1 | ELECTROLYTE FOR NON-AQUEOUS ELECTROLYTE CELL, AND NON-AQUEOUS ELECTROLYTE CELL WHEREIN SAME IS USED | CENTRAL GLASS CO., LTD. (JP) | 2021-01-28 | — | — | US | disclosed |
| US-10851124-B2 | Method for producing phosphoryl imide salt, method for producing nonaqueous electrolyte solution containing said salt, and method for producing nonaqueous secondary battery | CENTRAL GLASS CO., LTD. (JP) | 2020-12-01 | — | — | US | disclosed |
| US-10553904-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | CENTRAL GLASS CO., LTD. (JP) | 2020-02-04 | — | — | US | disclosed |
| EP-3261166-B1 | ELECTROLYTE FOR NONAQUEOUS-ELECTROLYTE CELL, AND NON-AQUEOUS ELECTROLYTE CELL IN WHICH SAME IS USED | CENTRAL GLASS CO LTD (JP) | 2019-11-20 | — | — | EP | disclosed |
| US-10424794-B2 | Ionic complex, electrolyte for nonaqueous electrolyte battery, nonaqueous electrolyte battery and ionic complex synthesis method | CENTRAL GLASS CO., LTD. (JP) | 2019-09-24 | — | — | US | disclosed |
| US-10211480-B2 | Electrolytic solution for non-aqueous electrolyte battery and non-aqueous electrolyte battery using the same | CENTRAL GLASS CO., LTD. (JP) | 2019-02-19 | — | — | US | disclosed |
| US-20180034103-A1 | ELECTROLYTE SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY, AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | CENTRAL GLASS CO., LTD. (JP) | 2018-02-01 | — | — | US | disclosed |
| US-20180034103-A1 | ELECTROLYTE SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY, AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | CENTRAL GLASS CO., LTD. (JP) | 2018-02-01 | — | — | US | disclosed |
| EP-3261166-A1 | ELECTROLYTE FOR NONAQUEOUS-ELECTROLYTE CELL, AND NON-AQUEOUS ELECTROLYTE CELL IN WHICH SAME IS USED | Central Glass Co., Ltd. (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-20170331143-A1 | ELECTROLYTIC SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | CENTRAL GLASS CO., LTD. (JP) | 2017-11-16 | — | — | US | disclosed |
| US-20170204124-A1 | Ionic Complex, Electrolyte for Nonaqueous Electrolyte Battery, Nonaqueous Electrolyte Battery and Ionic Complex Synthesis Method | CENTRAL GLASS COMPANY, LIMITED (JP) | 2017-07-20 | — | — | US | disclosed |
| US-20170204124-A1 | Ionic Complex, Electrolyte for Nonaqueous Electrolyte Battery, Nonaqueous Electrolyte Battery and Ionic Complex Synthesis Method | CENTRAL GLASS COMPANY, LIMITED (JP) | 2017-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11230564-B2 | Method for producing phosphoryl imide salt, method for producing nonaqueous electrolyte solution containing said salt, and method for producing nonaqueous secondary battery | PPM1F, PHOSPHO1, IPMK | CA1 322/4885CA2 134/4885CA7 413/4885 |
| US-11145904-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | ANO1, KCNN2, KCNN1 | CA1 134/4885CA2 225/4885CA7 285/4885 |
| US-10851124-B2 | Method for producing phosphoryl imide salt, method for producing nonaqueous electrolyte solution containing said salt, and method for producing nonaqueous secondary battery | PPM1F, PHOSPHO1, IPMK | CA1 322/4885CA2 134/4885CA7 413/4885 |
| US-20210054005-A1 | METHOD FOR PRODUCING PHOSPHORYL IMIDE SALT, METHOD FOR PRODUCING NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SAID SALT, AND METHOD FOR PRODUCING NONAQUEOUS SECONDARY BATTERY | PPM1F, PHOSPHO1, IPMK | CA1 322/4885CA2 134/4885CA7 413/4885 |
| US-20170204124-A1 | Ionic Complex, Electrolyte for Nonaqueous Electrolyte Battery, Nonaqueous Electrolyte Battery and Ionic Complex Synthesis Method | HCN2, KCNN4, KCNH3 | CA1 237/4885CA2 200/4885CA7 586/4885 |
| US-10553904-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | KCNN2, KCNN1, HCN2 | CA1 183/4885CA2 308/4885CA7 497/4885 |
| US-10424794-B2 | Ionic complex, electrolyte for nonaqueous electrolyte battery, nonaqueous electrolyte battery and ionic complex synthesis method | HCN2, KCNN4, KCNH3 | CA1 237/4885CA2 200/4885CA7 586/4885 |
| US-11171361-B2 | Electrolyte solution for non-aqueous electrolyte battery, and non-aqueous electrolyte battery using the same | KCNN1, KCNN2, ANO1 | CA1 146/4885CA2 464/4885CA7 645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.